Astrazeneca AZN
NYSE AZN
$163.70 +3.53 (+2.20%)
As of: Sep 14, 2026 · 3:06 PM EDT

Astrazeneca (AZN) Net Income Growth (3y) (2012 - 2026)

Analysis

Astrazeneca (AZN) Net Income Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Asml Holding 618.78 Bn 602.80 Bn 5.90 Bn -
2 Hsbc Holdings 362.62 Bn 362.62 Bn - -
3 General Electric 329.79 Bn 320.45 Bn 6.95 Bn 295.79%
4 Astrazeneca 253.78 Bn 248.49 Bn 12.86 Bn 9.46%
5 Citigroup 228.38 Bn -2,073.93 Bn 24.75 Bn -
6 Bhp 216.07 Bn 197.52 Bn - -
7 Rio Tinto 203.71 Bn 199.33 Bn - -
8 Diageo 197.09 Bn 195.06 Bn - -
9 Unilever 139.31 Bn 132.28 Bn - -
10 Hdfc Bank 117.84 Bn 80.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.46%
Mar 31, 2026 20.40%
Dec 31, 2025 178.35%
Sep 30, 2025 169.48%
Jun 30, 2025 205.11%
Mar 31, 2025 75.53%
Dec 31, 2024 58.45%
Sep 30, 2024 43.35%
Jun 30, 2024 43.10%
Mar 31, 2024 27.40%
Dec 31, 2023 74.01%
Sep 30, 2023 22.22%
Jun 30, 2023 25.78%
Mar 31, 2023 34.42%
Dec 31, 2022 47.69%
Sep 30, 2022 -27.86%
Jun 30, 2022 7.79%
Mar 31, 2022 -9.01%
Dec 31, 2021 -59.44%
Sep 30, 2021 -84.60%